Molecular Assemblies Closes Oversubscribed $24 Million Series A Financing to Advance Enzymatic DNA Synthesis toward Initial Commercial Access
News provided by
Share this article
Share this article
SAN DIEGO, April 15, 2021 /PRNewswire/ Molecular Assemblies, Inc., today announced that it has closed an oversubscribed $24 million Series A financing with significant investment from Agilent Technologies, iSelect Fund, Codexis, Alexandria Venture Investments, and Argonautic Ventures. In addition LYFE Capital has joined the syndicate. The proceeds of the financing will be used to advance the company s proprietary enzymatic DNA synthesis technology toward early commercialization efforts. We have made significant progress in advancing our proprietary enzymatic DNA synthesis technology, said Michael J. Kamdar, President and CEO of Molecular Assemblies. Over the past year, we ve entered into a transformative partnership with Codexis and joined a new project with GE Research to enabl
Molecular Assemblies Picks Up $24M For DNA Synthesis
socaltech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from socaltech.com Daily Mail and Mail on Sunday newspapers.
Molecular Assemblies Closes Oversubscribed $24 Million Series A Financing to Advance Enzymatic DNA Synthesis toward Initial Commercial Access
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
SAN DIEGO, March 2, 2021 /PRNewswire/
Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, today announced the company s participation in a new project with a multidisciplinary team, led by GE Research, to enable the production of DNA- and/or RNA-based vaccines and therapeutics, anywhere in the world in just days. The project is part of a new program from the
Defense Advanced Research Projects Agency (DARPA) called
NOW (Nucleic Acids On-Demand Worldwide). As part of the project, Molecular Assemblies will receive up to $6.5 million and contribute the company s proprietary enzymatic DNA synthesis technology, which uses aqueous, non-toxic reagents and is designed to deliver on-demand highly-pure, sequence-specific DNA.
Molecular Assemblies to Provide Enzymatic Synthesis Technology to DARPA NOW Project for On-Demand DNA/RNA Vaccine Manufacturing
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.